
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9205942
[patent_doc_number] => 20140005119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/931263
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16558
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931263
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/931263 | COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS | Jun 27, 2013 | Abandoned |
Array
(
[id] => 9269630
[patent_doc_number] => 20140024548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/923316
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 47707
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923316
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923316 | DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS | Jun 19, 2013 | Abandoned |
Array
(
[id] => 9462778
[patent_doc_number] => 20140127205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions'
[patent_app_type] => utility
[patent_app_number] => 13/923194
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10162
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923194
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923194 | Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions | Jun 19, 2013 | Issued |
Array
(
[id] => 9761719
[patent_doc_number] => 08846038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Method for treating synovial sarcoma'
[patent_app_type] => utility
[patent_app_number] => 13/918599
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 29307
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/918599 | Method for treating synovial sarcoma | Jun 13, 2013 | Issued |
Array
(
[id] => 9108370
[patent_doc_number] => 20130281502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'POST-TREATMENT BREAST CANCER PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/914617
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11568
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914617
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/914617 | POST-TREATMENT BREAST CANCER PROGNOSIS | Jun 9, 2013 | Abandoned |
Array
(
[id] => 11785955
[patent_doc_number] => 09395368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors'
[patent_app_type] => utility
[patent_app_number] => 13/914112
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 44
[patent_no_of_words] => 28990
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/914112 | Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors | Jun 9, 2013 | Issued |
Array
(
[id] => 10040318
[patent_doc_number] => 09081019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95'
[patent_app_type] => utility
[patent_app_number] => 13/911329
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 21
[patent_no_of_words] => 28922
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911329
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911329 | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 | Jun 5, 2013 | Issued |
Array
(
[id] => 9295203
[patent_doc_number] => 20140038837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/909022
[patent_app_country] => US
[patent_app_date] => 2013-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18431
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/909022 | BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER | Jun 2, 2013 | Abandoned |
Array
(
[id] => 9262138
[patent_doc_number] => 20130344067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/907798
[patent_app_country] => US
[patent_app_date] => 2013-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20190
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907798
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/907798 | ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF | May 30, 2013 | Abandoned |
Array
(
[id] => 9173835
[patent_doc_number] => 20130315819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS'
[patent_app_type] => utility
[patent_app_number] => 13/904039
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 129473
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/904039 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS | May 28, 2013 | Abandoned |
Array
(
[id] => 16197440
[patent_doc_number] => 10722577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Methods for treating GI syndrome and graft versus host disease
[patent_app_type] => utility
[patent_app_number] => 14/402875
[patent_app_country] => US
[patent_app_date] => 2013-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 14089
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402875
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402875 | Methods for treating GI syndrome and graft versus host disease | May 27, 2013 | Issued |
Array
(
[id] => 12527010
[patent_doc_number] => 10005846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Anti-transglutaminase 2 antibodies
[patent_app_type] => utility
[patent_app_number] => 14/402675
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 47
[patent_no_of_words] => 36206
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402675
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402675 | Anti-transglutaminase 2 antibodies | May 23, 2013 | Issued |
Array
(
[id] => 9173914
[patent_doc_number] => 20130315899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/901050
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27743
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901050
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901050 | METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS | May 22, 2013 | Abandoned |
Array
(
[id] => 12948601
[patent_doc_number] => 09835636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells
[patent_app_type] => utility
[patent_app_number] => 13/892011
[patent_app_country] => US
[patent_app_date] => 2013-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 4250
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13892011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/892011 | Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells | May 9, 2013 | Issued |
Array
(
[id] => 9003623
[patent_doc_number] => 20130224748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/890098
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26619
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890098
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/890098 | METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER | May 7, 2013 | Abandoned |
Array
(
[id] => 11930915
[patent_doc_number] => 09797906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Detectors of serum biomarkers for predicting ovarian cancer recurrence'
[patent_app_type] => utility
[patent_app_number] => 14/398773
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 12795
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398773 | Detectors of serum biomarkers for predicting ovarian cancer recurrence | May 5, 2013 | Issued |
Array
(
[id] => 11596851
[patent_doc_number] => 09644003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof'
[patent_app_type] => utility
[patent_app_number] => 14/397539
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6472
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397539 | RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof | May 5, 2013 | Issued |
Array
(
[id] => 11699968
[patent_doc_number] => 09689876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Methods related to cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 14/398377
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18141
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398377
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398377 | Methods related to cancer treatment | Apr 30, 2013 | Issued |
Array
(
[id] => 9518187
[patent_doc_number] => 20140154680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/873487
[patent_app_country] => US
[patent_app_date] => 2013-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18162
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13873487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/873487 | DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER | Apr 29, 2013 | Abandoned |
Array
(
[id] => 9408053
[patent_doc_number] => 20140099305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/865902
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15834
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865902
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865902 | COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY | Apr 17, 2013 | Abandoned |